AJANTPHARM

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Ajanta Pharma Limited

Ajanta Pharma Limited is a pharmaceutical formulation company in the Healthcare sector, specializing in Drug Manufacturers - Specialty & Generic. It develops, manufactures, and mar...

हिन्दी में

Ajanta Pharma Limited हेल्थकेयर क्षेत्र में एक फार्मास्युटिकल फॉर्मूलेशन कंपनी है, जो ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक उप-क्षेत्र में विशेषज्ञता रखती है। यह विशेष फार्म...

₹3,410.1-0.74%1D
Previous trading day close · Data updates after market close
1W: -2.2%
1M: -3.5%
6M: +17.7%
1Y: +40.3%
70/100
GoodResearch Score
Market Cap
₹39.9K Cr
Large Cap
P/E Ratio
37.56
Fair
P/B Ratio
9.41
Premium
ROE
25.4%
Strong
ROCE
29.4%
Excellent
Debt / Equity
0.06
Low debt
Div. Yield
1.9%
Low yield
EV/EBITDA
27.20
Expensive
52W Low: ₹2,380.2Current: ₹3,410.152W High: ₹3,796
At 73% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
88/100
Growth
Revenue, EPS, profit growth
82/100
Valuation
PE, PB, EV/EBITDA vs sector
25/100
Risk
Debt levels, volatility, coverage
89/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
37.56(Fair)
Forward P/E
29.27(Premium)
P/B Ratio
9.41(Premium)
P/S Ratio
7.38(Expensive)
EV/EBITDA
27.20(Expensive)
Dividend Yield
1.9%
5Y CAGR
18.6%(High growth)
Revenue Growth
24.8%(High)
Profitability
ROE
25.4%(Excellent)
ROCE
29.4%(Excellent)
ROA
19.3%(Efficient)
Net Margin
19.6%(High)
EBITDA Margin
29.0%
Financial Health
Debt to Equity
0.06(Low debt)
Current Ratio
2.64(Healthy)
Quick Ratio
1.98(Good)
Interest Coverage
86.52x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
38(Neutral)
RSI Exp (14)
36(Neutral)
MACD
-11.297(Bearish)
MACD Signal
2.138
BB Position
-12%(Lower band)
BB Width
5.54%(Normal)
ADX (14)
19.9(Sideways)
Williams %R
-88.4(Oversold)
MFI (14)
46(Neutral)
CCI (20)
-236(Oversold)
Stoch %K
12(Oversold)
ATR (14)
98.39(Avg True Range)
OBV (M)
9.3(Positive)
1W OBV Chg
-3.1%(Decreasing)
Rel Volume
1.30x(Normal)
Volatility
30.3%(Moderate)
Max DD 1Y
-30.1%(Moderate)
Alpha (CAPM)
31.32%(Outperforming Nifty)
Return vs Nifty
44.6%(Beating Nifty)
EMA 200
3194.8
EMA 50
3499.7
SMA 200
3126.0
vs SMA 50
-3.8%(Below SMA50)
vs SMA 200
9.1%(Above SMA200)
Volume
1.24L
Avg Vol 3M
1.0L
Shareholding Pattern
Promoter
66.2%
High confidence
FII
8.3%
DII / MF
18.4%
Strong MF interest
Share AJANTPHARM
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.